University of California, San Francisco: Neoplasms trials
The registry lists 33 Neoplasms studies with University of California, San Francisco as lead sponsor. 4 are open to participants now and 3 have results posted.
Phase 1 6Phase 2 2Phase 3 1No phase 25(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Music Therapy for Oral Mucositis Pain in Pediatric PatientsNot yet recruitingNCT07653360Not applicable
- Efficacy of Laser Interstitial Thermal Therapy in Young Persons With Low-grade GliomaRecruitingNCT07506239Not applicable
- Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRTRecruitingNCT06633224
- ChangeGradients: Promoting Adolescent Health Behavior ChangeRecruitingNCT04110756Not applicable
- MK-2206, Paclitaxel and Trastuzumab in Treating Patients With HER2-overexpressing Solid Tumor MalignanciesCompletedNCT01235897Phase 1Results posted
- A Study of Withdrawal of Immunosuppression and Donor Lymphocyte Infusions Following Allogeneic Transplant for Pediatric Hematologic MalignanciesCompletedNCT01036009Phase 2Results posted
- Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine TumorsTerminatedNCT00227617Phase 2/3Results posted
- Acute Risk Monitoring for Oncology Therapy RegimenCompletedNCT07601802
- Yoga to Improve Disparities in Cancer SurvivorshipCompletedNCT07165600Not applicable
- Tobacco Cessation Care for Cancer Patients by Automated Interactive OutreachCompletedNCT05829824Not applicable
- Discovering Cancer Risks From Environmental Contaminants and Maternal/Child HealthTerminatedNCT05746169
- Mobile App to Help Survivors of Childhood Cancer Navigate Long-Term Follow-Up CareCompletedNCT05641961Not applicable
- Interactive Mobile Doctor (iMD) to Promote Tobacco Cessation Among Cancer PatientsCompletedNCT05021185Not applicable
- Improving Cognition and Behavior in Pediatric Cancer Survivors Using a Novel Mindful Attention TrainingWithdrawnNCT05000905Not applicable
- Study of Attention and Memory Treatments for Cancer SurvivorsCompletedNCT04870320Not applicable
- Integrative Palliative Care/Psycho-Oncology Telehealth Intervention in Patients With Advanced CancerCompletedNCT04697524Not applicable
- Hypoxia-Specific Imaging to Predict Outcomes of Chimeric Antigen Receptor T-cell TherapyCompletedNCT04409314
- Impact of Phone Call About Financial Reimbursement Program on Access to Cancer Clinical TrialsTerminatedNCT03943082Not applicable
- Patient Portal and Navigation Program in Providing Information for Asian American Cancer PatientsCompletedNCT03867916Not applicable
- Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade GliomaCompletedNCT03739372Not applicable
- Pilot Study of Coil Arrays in Patients With Advanced Solid Tumor MalignanciesCompletedNCT02390011
- Visual Inspection With Acetic Acid Compared to Lugol's Iodine in HIV-infected WomenCompletedNCT02237326Not applicable
- Focal Ablation of Cervical PrecancerCompletedNCT01709773Not applicable
- Sirolimus With Cyclophosphamide and Topotecan for Pediatric/Adolescent Relapsed and Refractory Solid TumorsCompletedNCT01670175Phase 1
- Concordance of Two Endoscopic Procedures for Diagnosis of Carcinoma of the Upper Aerodigestive TractWithdrawnNCT01175499Not applicable
- ASA404 in Combination With Carboplatin/Paclitaxel/Cetuximab in Treating Patients With Refractory Solid TumorsWithdrawnNCT01031212Phase 1
- Panobinostat and Epirubicin in Treating Patients With Metastatic Malignant Solid TumorsCompletedNCT00878904Phase 1
- Pilot Study of Umbilical Cord Blood Transplantation in Adult Patient With Advanced Hematopoietic MalignanciesTerminatedNCT00514722Not applicable
- Pilot Study of Reduced-Intensity Umbilical Cord Blood Transplantation in Adult Patients Wtih Advanced Hematopoietic MalignanciesTerminatedNCT00513318
- Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic AnemiaCompletedNCT00513175
- Imatinib, Bevacizumab, and Cyclophosphamide in Patients With Refractory Metastatic Solid TumorsCompletedNCT00390156Phase 1
- Lapatinib and Paclitaxel in Treating Patients With Advanced Solid TumorsCompletedNCT00313599Phase 1
- Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic AnemiaStatus unknownNCT00295997Not applicable